Please login to the form below

Not currently logged in


This page shows the latest diabetes news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Provention Bio’s type 1 prevention drug teplizumab

FDA panel backs Provention Bio’s type 1 prevention drug teplizumab

A US Food and Drug Administration (FDA) panel has voted in favour of Provention Bio’s type 1 diabetes prevention drug teplizumab, setting it up for a potential approval in July. ... Compared to placebo, children and adults who were considered high-risk

Latest news

More from news
Approximately 359 fully matching, plus 1,394 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 14 fully matching, plus 172 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 66 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 16 fully matching, plus 121 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Stick or Twist? Healthcare brands in a (post) COVID-19 world